Last reviewed · How we verify
Tight blood pressure management
Tight blood pressure management is a Small molecule drug developed by Miodrag Filipovic, Prof. Dr. med.. It is currently in Phase 1 development.
At a glance
| Generic name | Tight blood pressure management |
|---|---|
| Sponsor | Miodrag Filipovic, Prof. Dr. med. |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- The GUARDIAN Pilot Trial (NA)
- Comprehensive Postpartum Management for Women With Hypertensive Disorders of Pregnancy (NA)
- The GUARDIAN Trial - Vasopressor Sub-Study (PHASE4)
- The GUARDIAN Trial - Induction Agent Sub-Study (PHASE4)
- The GUARDIAN Trial (NA)
- BP Management System User Acceptance Testing (NA)
- Management of Postpartum Preeclampsia (NA)
- Sex Differences in Myocardial Steatosis Induced Left Ventricular Dysfunction (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Tight blood pressure management CI brief — competitive landscape report
- Tight blood pressure management updates RSS · CI watch RSS
- Miodrag Filipovic, Prof. Dr. med. portfolio CI
Frequently asked questions about Tight blood pressure management
What is Tight blood pressure management?
Tight blood pressure management is a Small molecule drug developed by Miodrag Filipovic, Prof. Dr. med..
Who makes Tight blood pressure management?
Tight blood pressure management is developed by Miodrag Filipovic, Prof. Dr. med. (see full Miodrag Filipovic, Prof. Dr. med. pipeline at /company/miodrag-filipovic-prof-dr-med).
What development phase is Tight blood pressure management in?
Tight blood pressure management is in Phase 1.